MX9700225A - Improved methods for the determination and adjustment of prolactin daily rhythms. - Google Patents

Improved methods for the determination and adjustment of prolactin daily rhythms.

Info

Publication number
MX9700225A
MX9700225A MX9700225A MX9700225A MX9700225A MX 9700225 A MX9700225 A MX 9700225A MX 9700225 A MX9700225 A MX 9700225A MX 9700225 A MX9700225 A MX 9700225A MX 9700225 A MX9700225 A MX 9700225A
Authority
MX
Mexico
Prior art keywords
prolactin
profile
subject
comparing
determination
Prior art date
Application number
MX9700225A
Other languages
Spanish (es)
Inventor
Anthony H Cincotta
Albert H Meier
Original Assignee
Ergo Science Inc
Supervisors Of Lousian Board O
State University And Agricultu
And Mechanical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ergo Science Inc, Supervisors Of Lousian Board O, State University And Agricultu, And Mechanical College filed Critical Ergo Science Inc
Publication of MX9700225A publication Critical patent/MX9700225A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Control Of Transmission Device (AREA)
  • Fodder In General (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Eye Examination Apparatus (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

Disclosed are methods for detecting and adjusting abnormalities in prolactin daily rhythms. Provided is a method comparing a prolactin profile of a vertebrate subject to the prolactin profile of other vertebrate subjects having a normal prolactin profile; and adjusting the prolactin profile of the subject to cause the profile of the subject to conform to (or approach) the normal prolactin profile. Also provided is a method for evaluating the daily prolactin profile of a human subject wherein the method provides for comparing a set of at least two prolactin levels of the human and comparing them to corresponding prolactin levels for healthy humans (or a preestablished average prolactin curve for healthy humans) at the same time points. The method also provides for determining whether a human subject has an abnormal prolactin profile.
MX9700225A 1994-06-23 1995-06-23 Improved methods for the determination and adjustment of prolactin daily rhythms. MX9700225A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26455894A 1994-06-23 1994-06-23
PCT/US1995/009061 WO1996000396A1 (en) 1994-06-23 1995-06-23 Improved methods for the determination and adjustment of prolactin daily rhythms

Publications (1)

Publication Number Publication Date
MX9700225A true MX9700225A (en) 1997-04-30

Family

ID=23006606

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700225A MX9700225A (en) 1994-06-23 1995-06-23 Improved methods for the determination and adjustment of prolactin daily rhythms.

Country Status (14)

Country Link
EP (1) EP0769148A1 (en)
JP (1) JPH10503842A (en)
AU (1) AU3101395A (en)
BR (1) BR9508366A (en)
CA (1) CA2192855A1 (en)
CZ (1) CZ378796A3 (en)
FI (1) FI965146A (en)
HU (1) HUT76976A (en)
IL (1) IL114300A0 (en)
MX (1) MX9700225A (en)
NO (1) NO965507L (en)
SK (1) SK167396A3 (en)
WO (1) WO1996000396A1 (en)
ZA (1) ZA955192B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
US20100035886A1 (en) 2007-06-21 2010-02-11 Veroscience, Llc Parenteral formulations of dopamine agonists
EP2217073B1 (en) 2007-06-21 2019-10-09 VeroScience LLC Method of treating metabolic disorders and depression with dopamine receptor agonists
US8741918B2 (en) 2007-06-21 2014-06-03 Veroscience Llc Parenteral formulations of dopamine agonists
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659715A (en) * 1986-03-07 1987-04-21 Louisiana State University And Agricultural And Mechanical College Method of inhibiting body fat stores
US5066526A (en) * 1987-11-19 1991-11-19 Exxon Chemical Patents Inc. Thermoplastic films for use in stretch/cling applications
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates

Also Published As

Publication number Publication date
NO965507D0 (en) 1996-12-20
HU9603543D0 (en) 1997-02-28
JPH10503842A (en) 1998-04-07
HUT76976A (en) 1998-01-28
BR9508366A (en) 1997-09-30
EP0769148A1 (en) 1997-04-23
NO965507L (en) 1997-02-11
ZA955192B (en) 1996-05-07
AU3101395A (en) 1996-01-19
FI965146A0 (en) 1996-12-20
CA2192855A1 (en) 1996-01-04
FI965146A (en) 1996-12-20
CZ378796A3 (en) 1997-09-17
WO1996000396A1 (en) 1996-01-04
IL114300A0 (en) 1995-10-31
SK167396A3 (en) 1997-11-05

Similar Documents

Publication Publication Date Title
MY131392A (en) Improved methods for the determination and adjustment of prolactin daily rhythms
EP0733435A3 (en) Method of diagnosing pressing machine based on detected physical value as compared with reference
ZA975313B (en) Method and system for identifying at risk patients diagnosed with congestive heart failure
GR3031250T3 (en) Methods of diagnosing and treating preeclampsia
AU5117996A (en) Method and device for diagnosing and distinguishing chest pa in in early onset thereof
HK1043301A1 (en) Apparatus and method for performing presbyopia corrective surgery
AU5865600A (en) Method and apparatus for eye tracking
EP0858638A4 (en) Astigmatism measurement apparatus and method
AU5383796A (en) Method and apparatus for noninvasively determining hematocri t
AU1374395A (en) Method and apparatus for treating cardiovascular pathologies
IL110116A0 (en) Ophthalmic pachymeter and method of making ophthalmic determinations
AU3067295A (en) Apparatus for determining part of object, and object, part of which can be automatically determined
EP1464640A3 (en) 20-Epi-16-ene-25-OH-D3-analogs
EP0439545A4 (en) Methods of and compositions for diagnosing, monitoring and treating the early stages of osteosarthritis
MX9700225A (en) Improved methods for the determination and adjustment of prolactin daily rhythms.
AU8801191A (en) Clearance measurement system, video measurement vehicle and improved method of performing clearance measurements
IL91794A0 (en) Method and apparatus for diagnosing,monitoring and treating hypertension
AU2588600A (en) Method for determining asthma susceptibility
BG102064A (en) Method for increasing the retinal blood circulation
WO2004022131A3 (en) Anesthetic-state determining
WO2001080041A3 (en) Method and apparatus for detecting sleep disorders using the variability of the rr interval in an ecg waveform
IL126966A0 (en) Formulation and method for treating congestive heart failure
TW364955B (en) The method and apparatus for the control of a production system
DE59508630D1 (en) METHOD FOR DIAGNOSTIC EVALUATION AND COURSE CONTROL, AND MEDICINAL PRODUCTS FOR THE THERAPY OF SHOCK CONDITIONS IN PEOPLE
WO2000031541A3 (en) Method of detecting neurofibromatosis type 1